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Abstract
Background: This case study features a woman who presented with clinical and laboratory findings consistent
with hyperosmolar hyperglycemic non-ketotic syndrome (HHNS), systemic inflammatory response syndrome (SIRS),
and non-thyroidal illness syndrome (NTIS) who was noted to have a transient decrease in myocardial function. To
our knowledge, this is the first case discussing the overlapping pathophysiological mechanisms could increase
susceptibility to SIRS-induced cardiomyopathy. It is imperative that this clinical question be investigated further as
such a relationship may have significant clinical implications for prevention and future treatments, particularly in
patients similar to the one presented in this clinical case.
Case presentation: A 53-year old Caucasian female presented to the Emergency Department for cough, nausea,
vomiting and “feeling sick for 3 weeks.” Labs were indicative of diabetic ketoacidosis. Initial electrocardiograms
were suggestive of possible myocardial infarction and follow-up echocardiogram showed severely depressed left
ventricular systolic function which resolved upon treatment of ketoacidosis.
Conclusion: We suggest that her cardiomyopathy could have three synergistic sources: SIRS, HHNS and NTIS.
Overlapping mechanisms suggest uncontrolled diabetes mellitus and NTIS could increase susceptibility to
SIRS-induced cardiomyopathy as seen in this case. HHNS and SIRS cause cardiac tissue injury through mechanisms
including impairment of fatty acid oxidation and formation of reactive oxygen species, as well as modifying the
function of membrane calcium channels. As a result, it is conceivable that diabetes may amplify the deleterious effects
of inflammatory stressors on cardiac myocytes. This novel case report offers a path for future research into prevention
and treatment of SIRS-induced cardiomyopathy in, but not exclusive to, the setting of diabetes.
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Background
This case study features a woman who presented with
clinical and laboratory findings consistent with hyper-
osmolar hyperglycemic non-ketotic syndrome (HHNS),
systemic inflammatory response syndrome (SIRS), and
non-thyroidal illness syndrome (NTIS) who was noted
to have a transient decrease in myocardial function. We
suggest that her cardiomyopathy could have three syner-
gistic sources: SIRS, HHNS and NTIS. Overlapping
mechanisms suggest uncontrolled diabetes mellitus and
NTIS could increase susceptibility to SIRS-induced car-
diomyopathy as seen in this case.
Case presentation
A 53-year old female presented to the Emergency Depart-
ment for cough, nausea, vomiting and “feeling sick for
3 weeks.” She reported an allergy to penicillin but no
other significant past medical history. On initial assess-
ment, patient was afebrile, tachycardic (125 beats/minute),
tachypneic (22 breaths/minute), with blood pressure of
109/74 mmHg, and oxygen saturation of 72 % on room
air. Physical exam showed no other abnormalities.
Initial laboratories showed leukocytosis (WBC 22,000 k/
mcgl), hyperglycemia (glucose 796 mg/dl), hyponatremia
(Na 120 mEq/L; corrected 131 mEq/L), a hemoglobin A1c
of 17.2 %, and an elevated troponin T (0.19 ng/mL) and
BNP (2137 pg/mL). Measured osmolarity was 349 mOsm/
L with only small ketones in the blood and an arterial
lactate of 5.62 mmol/L. Arterial blood gas suggested
metabolic acidosis (pH = 7.264 | PCO2 = 25.9 mmHg |
Bicarbonate = 13 mmol/L). Calculated anion gap was
30 mEq/l. Chest X-ray showed bilateral reticular opacities
without cardiomegaly (Fig. 1). The patient was also found
to have an abnormal thyroid hormone profile suggesting
NTIS: TSH 1.35 mcgUI/mL (nr: 0.27–4.20), free T4
0.88 ng/dL (nr: 0.93–1.70), free T3 0.95 pg/ml (nr:2.30–
4.20), mixed hyperlipidemia, mild elevation of lipase and
amylase, and transaminitis.
Intravenous fluids, insulin and levofloxacin were started;
the patient’s clinical condition improved in 24 hours, al-
though she continued to complain of shortness of breath
and remained hypotensive. Blood and urine cultures were
ultimately negative. Initial EKG changes suggested previ-
ous myocardial infarction (Fig. 2). A transthoracic echo-
cardiogram demonstrated a severely depressed LV systolic
function (ejection fraction = 26 %), grade 2 diastolic dys-
function, and multiple regional wall motion abnormalities
(Fig. 3a-3b). However, on Day 4 after admission, a Myo-
view stress test showed no stress-induced ischemia, nor-
mal LV function, no regional wall motion abnormalities,
and an estimated ejection fraction of 50 %. A repeat
transthoracic echocardiogram performed on Day 7 dem-
onstrated an ejection fraction of 50–55 % (Fig. 3c-3d). A
follow-up EKG on Day 4 showed no significant changes
(Fig. 4).
On 6-month follow-up, the patient’s A1c remained ele-
vated but the NTIS and cardiomyopathy had resolved.
Her HgA1c was 9.4 %, TSH 1.86 mcgUI/mL (nr: 0.27–
4.20), free T4 1.01 ng/dl (nr: 0.93–1.70), free T3 2.89 pg/
ml (nr:2.30–4.20). BNP was 42 pg/ml (normal).
Discussion
Our patient presented a case of severe reversible myo-
cardial dysfunction with HHNS as debut of diabetes
mellitus, NTIS, and meeting SIRS criteria. Although sep-
sis of pulmonary origin was initially suspected, the clin-
ical course (normal body temperature, normalization in
blood leukocytes count in less than 24 and negative cul-
tures) suggest that SIRS was secondary to HHNS [1].
The observed NTIS was also likely secondary to HHNS
and SIRS.
Myocardial dysfunction is a common complication in
patients with SIRS secondary to sepsis and is associated
with an increased risk of mortality of up to 70–90 % [2,
3]. Systolic and diastolic myocardial dysfunction has
been described in other situations of SIRS such as severe
trauma and burns [4].
A common mechanism among these clinical situations
is a high level of pro-inflammatory cytokines such as
tumor necrosis alpha (TNF-alpha) and interleukin 6 (IL-
6). Bacterial products and pro-inflammatory cytokines
increase production of nitric oxide [5–7] and reactive
oxygen species (ROS) [8, 9] that inhibit the function of
proteins involved in myocardial contraction and relax-
ation [9, 10].
The sarcoendoplasmic reticulum adenosine triphospha-
tase 2a (SERCA2a) and sarcolemmal voltage-gated L-type
calcium channels are often affected. As a consequence,
Ca2+ entry into cells and release from sarcoplasmic
reticulum (SR) decreases and sarcomere shortening is
Fig. 1 Chest X-ray, Portable film notable for bilateral, patchy
hilar infiltrates consistent with pulmonary edema in the setting
of depressed ejection fraction
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Fig. 2 Initial EKG, EKG taken at admission notable for q-waves in the septal leads consistent with prior myocardial infarction. There are no findings
concerning for acute ischemia
Fig. 3 Transthoracic echocardiogram at Day 1 and Day 7, Apical four chamber view from day 1 transthoracic echocardiogram (TTE) with IV
contrast at end-diastole a and end-systole b demonstrates depressed left ventricular (LV) ejection fraction estimated at 26 %. Apical four chamber
view from day 7 TTE at end-diastole c and end-systole d demonstrates normalized LV ejection fraction
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reduced [11, 12]. Bacterial products and pro-inflammatory
cytokines also inhibit SERCA2a gene expression [13], re-
duce myofilament sensitivity to Ca2+ [14], and downregu-
late and desensitize beta-adrenergic receptors [15, 16].
SIRS can cause myocardial energy deficiency. Low
ATP levels and a decrease in the phosphocreatine/ATP
ratio have been found in deadly cases of septic shock
[17–19]. Both glucose oxidation and fatty acid oxidation
(FAO), the main sources of myocardial ATP, decrease in
non-surviving humans with septic shock [20]. Pyruvate
dehydrogenase complex [21] and phosphofructokinase
activities [22] decrease during septic shock leading to
dissociation of glycolysis from glucose oxidation.
Factors responsible for FAO inhibition during septic
shock are a decrease in mitochondrial membrane car-
nitine shuttle activity and a decrease in peroxisome
proliferator-activated receptor alpha and peroxisome
proliferator-activated receptor gamma co-activator-1α
gene expression [23, 24]. Also, mitochondrial complexes I,
II and III activities decrease in cases of prolonged septic
shock [25, 26]. Multiple reviews have been published to
discuss these and other possible mechanisms of sepsis-
induced cardiomyopathy [8, 27–30].
Acute hyperglycemic crisis can cause SIRS, and both
hyperosmolar hyperglycemic non-ketotic syndrome and
diabetic ketoacidosis are associated with a severe inflamma-
tory state [31]. However, other features of hyperglycemic
crisis, such as dehydration and electrolyte imbalance, likely
exacerbated the patient’s cardiomyopathy.
Diabetic cardiomyopathy refers to ventricular dysfunc-
tion in the absence of coronary artery disease and hyper-
tension [32]. Diastolic and systolic dysfunction can be
seen as early functional alteration of diabetic cardiomy-
opathy [32]. The pathogenic mechanisms involved are
complex, interrelated and not all well characterized, al-
though inflammation seems to play a significant role
[32]. Under normal circumstances, the heart obtains
energy mostly from FAO. In diabetic hearts, glucose
uptake, glycolysis and glucose oxidation are reduced [32]
and FA uptake increased. An increase in FA uptake is
associated with increased triglycerides synthesis that
causes myocardial lipotoxicity and cell death. Also,
higher FAO rates increase oxygen consumption at the
expense of mitochondrial uncoupling and increased oxi-
dative stress. Our patient had elevated troponin T levels
indicating cellular death or myocardial cell membrane
alterations. Additionally, the hyperosmolar state may cause
dehydration, which would decrease preload and further
lower left ventricular systolic function.
Our patient also presented with low thyroid hormone
levels with normal TSH, a condition known as NTIS or
sick euthyroid syndrome. Although NTIS is probably the
most common cause of hypothyroidism, the current
consensus advises against the administration of thyroid
Fig. 4 Follow-up EKG on Day 4 of hospitalization
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hormones to patients with NTIS as thyroid hormones
increase respiratory rate, oxygen consumption, energy
expenditure and heat production, NTIS is considered an
adaptive response to counteract catabolism during
illness [33], and this is the primary reasoning against
administration of thyroid hormone to patients with
NTIS [34]. However, SIRS is associated with myocar-
dial hypothyroidism in large animal models of septic
shock [35] and hypothyroidism can cause systolic
and diastolic myocardial dysfunction. In this context, thy-
roid hormone administration, in attempt to normalize
thyroid hormone levels inside the myocardium, could
have been beneficial and devoid of harmful effects. In fact,
hypothyroidism increases serum levels of troponin T and
creatine kinase CK-MB isoenzymes that are markers of
myocardial damage. Patients with heart failure and low
serum T3 have poor hemodynamics and a higher prob-
ability of death [36]. Finally, thyroid hormone administra-
tion to patients with advanced congestive heart failure was
well tolerated and increased cardiac output without an ap-
preciable increase in ischemia or arrhythmias [36–38].
Conclusion
As we have explained, both HHNS and SIRS cause car-
diac tissue injury through similar mechanisms including
impairment of fatty acid oxidation and formation of re-
active oxygen species, as well as modifying the function
of membrane calcium channels. As a result, it is con-
ceivable that diabetes may amplify the deleterious effects
of inflammatory stressors on cardiac myocytes. It is im-
perative that this clinical question be investigated further
as such a relationship may have significant clinical impli-
cations for prevention and future treatments, particularly
in patients similar to the one presented in this clinical
case.
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